-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Nuvation Bio, Raises Price Target to $21

Benzinga·07/27/2026 12:21:26
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Nuvation Bio (NYSE:NUVB) with a Buy and raises the price target from $17 to $21.